Key result
Cardiac calcified amorphous tumor is a rare non-neoplastic intracardiac mass for which more data are required to develop evidence-based approaches to diagnosis, treatment, and follow-up.
Cardiac calcified amorphous tumor is a rare non-neoplastic mass requiring more data to develop evidence-based management strategies.
Calcified amorphous tumor (CAT) of the heart is a rare non-neoplastic intracardiac mass first described in 1997 by Reynolds et al.1 Although case reports of cardiac CAT have been published since, early attempts at identifying characteristic features of this condition and distinguishing it from other cardiac masses relied on limited information.2,3 More data on cardiac CAT are required to develop evidence-based approaches to its diagnosis, treatment, appropriate follow-up, and possibly prevention strategies.
No takes yet. Share an insight, caveat, or question.
Shah et al. (2018) conducted a review in Cardiac Calcified Amorphous Tumor. Cardiac calcified amorphous tumor is a rare non-neoplastic intracardiac mass for which more data are required to develop evidence-based approaches to diagnosis, treatment, and follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: